Table 2.
No. | Tumor location | Tumor size (mm) | Abscess size (mm) | Stage | Histology | Surgery (procedure) | CR | OT (mins) | Bleeding (mL) | Post-operative mobiditya | Survival (months) | Cause of death |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | LUL | 75 | 68 | IIIA | ADC | L (O) | – | 322 | 210 | Recurrent LNP (G3) | 114.5 (A) | – |
2 | RUL | 55 | 54 | IV | ADC | L (O) | – | 415 | 3134 | SVA (G2) | 27.7 (D) | LC |
3 | RUL | 90 | 80 | IV | SqCC | L (O) | – | 456 | 2196 | – | 1.3 (D) | LC |
4 | LLL | 51 | 50 | IIA | ADC | L (O) | MP | 349 | 1327 | – | 57.3 (A) | – |
5 | RLL | 35 | 34 | IIA | SqCC | L (O) | – | 274 | 644 | CI (G2) | 16.1 (D) | LC |
6 | RLL | 36 | 35 | IIA | SCC | L (O) | – | 222 | 170 | – | 35.7 (A) | – |
7 | RUL | 31 | 25 | IIB | ADC | L (V) | PP | 235 | 75 | – | 16.4 (A) | – |
8 | LUL | 60 | 55 | IIA | SqCC | L (O) | CW | 323 | 63 | SCA (G2) | 11.1 (A) | – |
9 | RUL | 55 | 92b | IV | SqCC | P (O) | PP | 347 | 1930 | SVA (G2) | 8.57 (A) | – |
10 | RLL | 107 | 96 | IIB | LCNEC | L (O) | – | 346 | 1369 | Hypoxemia (G2) | 11.4 (D) | LC |
11 | RLL | 75 | 74 | IIIA | ADC | B (O) | – | 421 | 1450 | BPF (G4) | 9.2 (D) | Pneumonia |
aCommon Terminology Criteria for Adverse Events, version 4.0
bSize of abscess and necrosis of whole lung lobe
Abbreviations: A alive, ADC adenocarcinoma, B bilobectomy, BPF bronchopleural fistula, CI cerebral infarction, CR combined resection, CW chest wall, D deceased, G grade, L lobectomy, LC lung cancer, LCNEC large cell neuroendocrine carcinoma, LLL left lower lobe, LNP laryngeal nerve paresis, LUL left upper lobe, MP mediastinal pleura, No., number O open thoracotomy, OT, operative time, P pneumonectomy, PP parietal pleura, RLL right lower lobe, RUL right upper lobe, SCA subcutaneous abscess, SCC spindle cell carcinoma, SqCC squamous cell carcinoma, SVA supraventricular arrhythmia, V video-assisted thoracoscopic surgery